These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36621353)

  • 1. Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS).
    Barone PW; Keumurian FJ; Neufeld C; Koenigsberg A; Kiss R; Leung J; Wiebe M; Ait-Belkacem R; Azimpour Tabrizi C; Barbirato C; Beurdeley P; Brussel A; Cassart JP; Cote C; Deneyer N; Dheenadhayalan V; Diaz L; Geiselhoeringer A; Gilleece MM; Goldmann J; Hickman D; Holden A; Keiner B; Kopp M; Kreil TR; Lambert C; Logvinoff C; Michaels B; Modrof J; Mullan B; Mullberg J; Murphy M; O'Donnell S; Peña J; Ruffing M; Ruppach H; Salehi N; Shaid S; Silva L; Snyder R; Spedito-Jovial M; Vandeputte O; Westrek B; Yang B; Yang P; Springs SL
    Biologicals; 2023 Feb; 81():101661. PubMed ID: 36621353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals.
    Khan AS; Blümel J; Deforce D; Gruber MF; Jungbäck C; Knezevic I; Mallet L; Mackay D; Matthijnssens J; O'Leary M; Theuns S; Victoria J; Neels P
    Biologicals; 2020 Sep; 67():94-111. PubMed ID: 32660862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing.
    Cleveland MH; Anekella B; Brewer M; Chin PJ; Couch H; Delwart E; Huggett J; Jackson S; Martin J; Monpoeho S; Morrison T; Ng SHS; Ussery D; Khan AS
    Biologicals; 2020 Mar; 64():76-82. PubMed ID: 32094072
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    MacDonald ML; Polson SW; Lee KH
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
    Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
    PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Evaluation of Next-Generation Sequencing Performance Relative to qPCR and In Vitro Cell Culture Tests for Human Cytomegalovirus.
    Ng SH; Azizi A; Edamura K; Malott RJ; Charlebois RL; Logvinoff C; Schreiber M; Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):563-71. PubMed ID: 25475630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 2019 Viral Clearance Symposium, Session 7: Cell Banks and U.S. Pharmacopeia.
    O'Donnell S
    PDA J Pharm Sci Technol; 2022; 76(4):358-361. PubMed ID: 34911823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IABS/DCVMN webinar on next generation sequencing.
    Khan AS; Theuns S; Mallet L; Cirefice G; Bhuller R; Goios A; Suri R; Neels P
    Biologicals; 2023 Feb; 81():101662. PubMed ID: 36543633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of adventitious agents using next-generation sequencing.
    Richards B; Cao S; Plavsic M; Pomponio R; Davies C; Mattaliano R; Madden S; Klinger K; Palermo A
    PDA J Pharm Sci Technol; 2014; 68(6):651-60. PubMed ID: 25475640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for new technologies for detection of adventitious agents in vaccines and other biological products.
    Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):556-62. PubMed ID: 25475629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a sample preparation workflow for advanced virus detection and understanding sensitivity by next-generation sequencing.
    Wang CJ; Feng SF; Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):579-88. PubMed ID: 25475632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.
    Khan AS; Benetti L; Blumel J; Deforce D; Egan WM; Knezevic I; Krause PR; Mallet L; Mayer D; Minor PD; Neels P; Wang G
    Biologicals; 2018 Sep; 55():1-16. PubMed ID: 30093175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products.
    Gombold J; Karakasidis S; Niksa P; Podczasy J; Neumann K; Richardson J; Sane N; Johnson-Leva R; Randolph V; Sadoff J; Minor P; Schmidt A; Duncan P; Sheets RL
    Vaccine; 2014 May; 32(24):2916-26. PubMed ID: 24681273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection.
    Charlebois RL; Ng SH; Gisonni-Lex L; Mallet L
    PDA J Pharm Sci Technol; 2014; 68(6):602-18. PubMed ID: 25475635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel evaluation of broad virus detection methods.
    Modrof J; Berting A; Kreil TR
    PDA J Pharm Sci Technol; 2014; 68(6):572-8. PubMed ID: 25475631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a new RNA next generation sequencing approach for the specific detection of virus infection in cells.
    Brussel A; Brack K; Muth E; Zirwes R; Cheval J; Hebert C; Charpin JM; Marinaci A; Flan B; Ruppach H; Beurdeley P; Eloit M
    Biologicals; 2019 May; 59():29-36. PubMed ID: 30992161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical approach to a viral detection pipeline using existing viral and non-viral sequence resources.
    Bekkari K; Shpungin J; Thompson JR
    PDA J Pharm Sci Technol; 2014; 68(6):595-601. PubMed ID: 25475634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current testing methods and challenges for detection of adventitious viruses.
    Khan AS
    PDA J Pharm Sci Technol; 2011; 65(6):627-33. PubMed ID: 22294589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.
    Mee ET; Preston MD; Minor PD; Schepelmann S;
    Vaccine; 2016 Apr; 34(17):2035-43. PubMed ID: 26709640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of approaches to viral safety issues for biological products.
    Lubiniecki AS
    PDA J Pharm Sci Technol; 2011; 65(6):547-56. PubMed ID: 22294576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.